Position in ZTS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$186,548
-$179,430 QoQ
Shares Held
2,596
-16.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,064
of 1,408 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2026CallValue
$3,546
CallShares
30
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Strive Financial Group ,LLC holds $209,883 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (88.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
2,596 | $186,548 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
650 | $11,674 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
250 | $4,327 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
100 | $3,467 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
100 | $3,388 | |
| 6 | HLN |
Haleon plc
|
39 | $363 | |
| 7 | EVO |
Evotec SE
|
41 | $114 | |
| 8 | SBFM |
Sunshine Biopharma Inc.
|
1 | $2 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,548 | 2,596 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $365,978 | 3,096 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $3,546 | 30 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $389,538 | 3,096 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||